Home Products See our Complete biomarker list See the list Panels Cardiometabolic panel Cell Regulation panel Cardiovascular II panel Cardiovascular III panel Development panel Immune Response panel Immuno-Oncology panel Inflammation panel Metabolism panel Neurology panel Neuro Exploratory panel Oncology panel Organ Damage panel Mouse Exploratory panel Other Olink Explorer Using Olink with other sample matrices Olink with other species Statistical Packages Document download center FAQ Analysis Service Analysis Service Uppsala Analysis Service Boston Data you can trust Our PEA technology Data generation and QC Transparent data validation Publications Customer testimonials Webinars About us Contact us Integrity Policy News and events Working at Olink Our vision Press releases Collaborative projects Service providers Olink Bioscience Technology In situ detection Protein Biomarker Discovery Welcome to Olink Proteomics! View our unique offering Read our FAQs! Why choose Olink for targeted protein biomarker discovery? High quality data that you can trust The rapid high throughput analysis that your studies deserve The most effective use of your precious samples Read more Testimonials Olink has developed a very innovative technology that has a simplicity approach to be able to measure large numbers of proteins. That’s a significant breakthrough for investigators to break into a field of diseases that you could not explore without this technology. Professor C.Thomas Caskey, Baylor College of Medicine, Houston TX. I am very pleased with the Olink methodology, which has revealed several new biomarkers in the CSF and plasma from patients with multiple sclerosis. It was of particular interest to be able to detect markers in plasma that reflect neuronal damage, including neurofilament light chains Professor Tomas Olsson, Center for Molecular Medicine, Karolinska Hospital, Stockholm. We are impressed by the quality of data delivered by the Olink technology with very small sample sizes. The application in the field of precision medicine is extremely promising. Professor Mathias Uhlen, Science for Life Laboratory & Royal Institute of Technology (KTH), Stockholm Olink’s immunoassay panels are very useful tools for targeting and discovering protein dynamics in our longitudinal studies, such as the integrative personal omics profile (iPOP) Professor Mike Snyder, Department of Genetics, Stanford University The Olink panel provided some directions we wouldn’t have considered previously, and is a very appealing strategy for neuroscience projects hoping to identify novel CSF biomarkers Tom Lanz, Principal Scientist, Pfizer Neuroscience In profiling the immune systems of newborn children, the Olink panels allow us to maximize the amount of information extracted from a few microliters of plasma. Assistant Professor Petter Brodin, Department of Medicine, Karolinska Institute, Stockholm. Read more about what our customers say about us Publications Olin et al 2018 Stereotypic immune system development in newborn children. (Landmark publication in Cell). Read more Chowdry et al 2018 A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes (in Nature) Read more Tromp et al 2018 Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction. Read more Ouwerkerk et al 2018 Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure : Results From BIOSTAT-CHF. Read more See all publications News & Events Highlights Petter Brodin - in his own words A story from the Olink user community. Petter Brodin talks about his landmark study (Ol... Read more Webinar - Driving precision medicine through biostatistics: Translating multiomics biomarker data into breakthrough knowledge Olink-sponsored Science/AAAS webinar on October 3, 2018 Are you inter... Read more Olink NEURO EXPLORATORY panel now available Olink is delighted to announce the launch of a new biomarker panel that complements an... Read more White paper on study design now available “Strategies for design of protein biomarker studies” is a new white paper that describ... Read more See all Olink news (Sept 20, 2018) Science/AAAS webinar on leveraging biostatistics for precision medicine “Translating multiomics biomarker data into breakthrough knowledge” will feature presentations by Dr. Eric Fauman (Pfizer, USA) & Dr. Jasper Tromp (University Medical Centre Groningen, Groningen, The Netherlands) and will be broadcast live on Wednesday, October 3, 2018, 12 noon Eastern, 9 a.m. Pacific, 5 p.m. UK (BST), 6 p.m. Central Europe (CEST). If you cannot join the live event, register anyway and watch an on-demand recording later at your own convenience. Read more ! Register now! " frameborder="0" allowfullscreen> Share in our company vision! View the video and see where Olink Proteomics is today (at the forefront of targeted protein biomarker discovery), and where we see our future, in the development of precision diagnostics and the realization of precision medicine. Learn more about our vision Read about our panels 1073 BIOMARKER ASSAYS 647 000 SAMPLES ANALYZED 184 PUBLICATIONS Olink Essentials Our Innovation Learn more about our technology and how it can meet your biomarker discovery needs Our Products Learn more about our growing range of protein biomarker panels Our Transparency Learn more about our rigorous assay QC and validation process and see the data Our Expertise Learn more about Olink's Analysis Service: our in-house experts are here to run your assays for you Do you want to know more? Fill in the form and we will contact you as soon as we can. Contact Me Sitemap Welcome to Olink Products Analysis Service Data you can trust About us Olink Bioscience Contact Email: info@olink.com Phone number: +46 (0)18 - 444 39 70 Social media Copyright 2018 Olink Created with by wasabiweb We use cookies to optimize your experience on our website. By choosing to continue, you acknowledge acceptance of our use of cookies. Learn more about cookies here. Do not show this message again